# BLUJEPA
> **NDA218230** · New Drug Application · Sponsor: GLAXOSMITHKLINE · Approved 2025-03-25
## Drug
- **FDA Application Number:** NDA218230
- **Application type:** New Drug Application
- **Brand name:** BLUJEPA
- **Generic name:** GEPOTIDACIN
- **Active ingredients:** GEPOTIDACIN MESYLATE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** GLAXOSMITHKLINE
- **Manufacturer:** GlaxoSmithKline LLC
- **First approval:** 2025-03-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218230)
---
*AI Analytics · CC0 1.0*